A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of escalating doses of
GS-9411 in healthy male volunteers. GS-9411 is a sodium channel inhibitor, that may restore
airway hydration and mucociliary clearance in the lung.